|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 AUD | -3.70% |
|
+8.33% | +8.33% |
| 05-13 | AdAlta Signs Master Services Agreement with Cell Therapies; Shares Up 4% | MT |
| 04-29 | AdAlta Secures Up to AU$3.7 Million for MOU, i-body Programs | MT |
AdAlta Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported revenue was AUD 2.76 million compared to AUD 3.99 million a year ago. Net loss was AUD 6.06 million compared to AUD 5.63 million a year ago.
Basic loss per share from continuing operations was AUD 0.0218 compared to AUD 0.024 a year ago. Diluted loss per share from continuing operations was AUD 0.0218 compared to AUD 0.024 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.33% | 9.56M | |
| +10.27% | 115B | |
| +11.97% | 106B | |
| -5.84% | 24.69B | |
| -1.22% | 21.97B | |
| -4.83% | 19.27B | |
| -11.82% | 17.56B | |
| -39.36% | 17.32B | |
| +5.68% | 14.03B | |
| +33.15% | 12.13B |
ADALTA LIMITED 
